News (category : Scientific - Pipeline

News (category : Scientific - Pipeline - Regulatory). http://www.lifescience-online.com/ News Feed Powered by Lifescience-online.com en-us Wed, 08 Feb 2012 04:21:51 +0100 Wed, 08 Feb 2012 04:21:51 +0100 News Lifescience-online http://rss.lifescience-online.com/images/logo.gif http://www.lifescience-online.com/ Lifescience-online Anacor Pharmaceuticals Announces That Its Partner GSK Has Voluntarily Paused Enrollment of Ongoing GSK ?052 Phase 1 and 2 Clinical Trials http://www.lifescience-online.com/Anacor_Pharmaceuticals_Announces_That_Its_Partner_,30797.html?portalPage=Lifescience+Today.News

Area :: Anti-Infective
Category :: Scientific - Pipeline - Regulatory
Related companies :: GLAXOSMITHKLINE PLC
Anacor Pharmaceuticals Inc
Related drugs :: AN-3365

]]> Sun, 05 Feb 2012 23:00:00 GMT News Idenix Announces Removal of the Partial Clinical Hold on HCV Nucleotide Inhibitor, IDX184 http://www.lifescience-online.com/Idenix_Announces_Removal_of_the_Partial_Clinical_H,30795.html?portalPage=Lifescience+Today.News

Area :: Anti-Infective
Category :: Scientific - Pipeline - Regulatory
Related companies :: IDENIX PHARMACEUTICALS INC
Related drugs :: IDX-184

]]> Thu, 02 Feb 2012 23:00:00 GMT News Lubiprostone Meets Primary Endpoint in Phase 3 Clinical Trial for Opioid-Induced Bowel Dysfunction (OBD) http://www.lifescience-online.com/Lubiprostone_Meets_Primary_Endpoint_in_Phase_3_Cli,30777.html?portalPage=Lifescience+Today.News

Area :: Gastrointestinal
Category :: Scientific - Pipeline - Regulatory
Related companies :: SUCAMPO PHARMACEUTICALS INC
Related drugs :: LUBIPROSTONE

]]> Wed, 01 Feb 2012 23:00:00 GMT News Agennix AG Halts Phase II/III OASIS Trial in Severe Sepsis Print http://www.lifescience-online.com/Agennix_AG_Halts_Phase_II_III_OASIS_Trial_in_Sever,30778.html?portalPage=Lifescience+Today.News

Area :: Immunomodulation
Category :: Scientific - Pipeline - Regulatory
Related companies :: AGENNIX AG
Related drugs :: TALACTOFERRIN

]]> Wed, 01 Feb 2012 23:00:00 GMT News FDA Approves JANUMET(R) XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of JANUMET(R) (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience http://www.lifescience-online.com/FDA_Approves_JANUMET__XR__sitagliptin_and_metformi,30784.html?portalPage=Lifescience+Today.News

Category :: Scientific - Pipeline - Regulatory
Related companies :: MERCK AND CO INC
Related drugs :: SITAGLIPTIN + METFORMIN

]]> Wed, 01 Feb 2012 23:00:00 GMT News FDA approves Novartis drug Glivec(R) label recommending extending treatment to three years for certain GIST patients after surgery http://www.lifescience-online.com/FDA_approves_Novartis_drug_Glivec__label_recommend,30767.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: NOVARTIS AG
Related drugs :: IMATINIB MESYLATE

]]> Tue, 31 Jan 2012 23:00:00 GMT News AB Science Reports Positive Clinical Study Data: Masitinib Significantly Extends Overall Survival as compared to Pfizer?s Sutent(R) in Gleevec(R)-resistant GIST http://www.lifescience-online.com/AB_Science_Reports_Positive_Clinical_Study_Data__M,30768.html?portalPage=Lifescience+Today.News

Area :: Oncology
Category :: Scientific - Pipeline - Regulatory
Related companies :: AB SCIENCE
Related drugs :: MASITINIB

]]> Tue, 31 Jan 2012 23:00:00 GMT News Athersys Announces Positive Results of MultiStem(R) Clinical Trial for Hematopoietic Stem Cell Transplant Support and Prevention of Graft-Versus-Host Disease http://www.lifescience-online.com/Athersys_Announces_Positive_Results_of_MultiStem_R,30772.html?portalPage=Lifescience+Today.News

Area :: Cardiovascular
Category :: Scientific - Pipeline - Regulatory
Related companies :: ATHERSYS
Related drugs :: MULTISTEM

]]> Tue, 31 Jan 2012 23:00:00 GMT News